medigraphic.com
Archivos de Medicina (Manizales)

2021, Number 2

<< Back Next >>

Arch Med 2021; 21 (2)

Complementary therapies in migraine and related variables. European Survey

Vicente-Herrero Mª-Teófila, Ramírez-Iñiguez-de-la-Torre Mª-Victoria, Ruiz-de-la-Torre E, Reinoso-Barbero L

Language: Spanish
References: 26
Page: 492-502
PDF size: 718.33 Kb.


ABSTRACT

Objective: to evaluate the use of alternative non-pharmacological therapies in migraine and related variables. Migraine affects one in ten people worldwide, with a growing increase and a higher prevalence among women in urban areas. Although the usual treatments are pharmacological, the use of alternative tech-niques is increasing. Materials and methods: cross-sectional observational study by anonymous web survey of 3,342 patients from European countries on the use of alternative therapies. Study variables: age, gender, country, type of locality, ed-ucational level, rural or urban setting and treatment response. Results: the use of alternative therapies in migraine treatment is a growing phenomenon, with greater use in patients between 41-60 years of age and higher education. Conclusions: in Migraine, differences are observed by age, gender, cultural level and country of origin. The use of complementary medicine as an therapeutic alternative in migraine is uncommon and should be investigated in greater depth, establishing relationships that allow supporting the affected patient and prioritizing, if possible, some over others with scientific evidence.


REFERENCES

  1. Woldeamanuel YW, Cowan RP. Migraine affects 1 in 10 people worldwide featuring recent rise: A systematic review and meta-analysis of com-munity-based studies involving 6 million partic-ipants. J Neurol Sci.2017;372:307-315. DOI: 10.1016/j.jns.2016.11.071

  2. Wang X, Zhou HB, Sun JM, Xing YH, Zhu YL, Zhao YS. The prevalence of migraine in university students: a systematic review and meta-analysis. Eur J Neurol. 2016; 23(3):464-475. https://doi.org/10.1111/ene.12784

  3. Robbins MS, Lipton RB. The epidemiology of pri-mary headache disorders. Semin Neurol. 2010; 30(2):107-119. http://dx.doi.org/10.1055/s-0030-1249220

  4. Kamm K, Ruscheweyh R, Eren O, Straube A. The Classification of Headache: Important Aspects of Patient’s History and Clinical Diagnostic. Dtsch Med Wochenschr. 2017; 142(6):409-417. DOI: 10.1055/s-0042-116383

  5. Carbaat PA, Couturier EG. Headache: classifica-tion and diagnosis. Ned Tijdschr Tandheelkd. 2016; 123(11):539-544. DOI: 10.5177/ntvt.2016.11.16122

  6. Rizzoli P, Mullally WJ. Headache. Am J Med. 2018; 131(1):17-24. DOI: 10.1016/j.amjmed.2017.09.005

  7. Cuéllar Rodríguez S. Migraña. Panorama Actual Med. 2018; 42(415):634-653.

  8. Millstine D, Chen CY, Bauer B. Complementary and integrative medicine in the management of headache. BMJ. 2017; 357:1-3. DOI: 10.1136/bmj.j1805

  9. Vicente-Herrero MT, Ruiz-de la Torre E, Reinoso Barbero L. Trabajo y migraña. Encuesta euro-pea. Medicina Balear. 2019; 34(3):30-37. DOI:10.3306/MEDICINABALEAR.34.03.30

  10. Vicente-Herrero MT, Ramírez-Iñiguez-de-la-Torre MV, Capdevila-García L. Asociación Española de Especialistas en Medicina del Trabajo (AEEMT). Resumen de conclusiones. Encuesta Europea Trabajo y Migraña. Madrid:EMHA; 2019.

  11. Buse DC, Loder EW, Gorman JA, Stewart WF, Reed ML, Fanning KM, et al. Sex differences in the prevalence, symptoms, and associated features of migraine, probable migraine and other severe headache: results of the American Migraine Prev-alence and Prevention (AMPP) Study. Headache.2013; 53(8):1278-99.

  12. Buse D, Manack A, Serrano D, Reed M, Varon S, Turkel C, et al. Headache impact of chronic and episodic migraine: results from the American Migraine Prevalence and Prevention study. Headache. 2012; 52(1):3-17. DOI: 10.1111/j.1526-4610.2011.02046.x

  13. Befus DR, Irby MB, Coeytaux RR, Penzien DB. A Critical Exploration of Migraine as a Health Disparity: the Imperative of an Equity-Oriented, Intersectional Approach. Curr Pain Headache Rep. 2018; 22(12):79. DOI: 10.1007/s11916-018-0731-3

  14. Müller KI, Alstadhaug KB, Bekkelund SI. Accept-ability, Feasibility, and Cost of Telemedicine for Non acute Headaches: A Randomized Study Comparing Video and Traditional Consultations. J Med Internet Res. 2016; 18(5):e140. DOI: 10.2196/jmir.5221

  15. Wells RE, Baute V, Wahbeh H. Complementary and Integrative Medicine for Neurologic Conditions. Med Clin North Am. 2017; 101(5):881-93. DOI: 10.1016/j.mcna.2017.04.006

  16. Wells RE, Beuthin J, Granetzke L. Complementary and Integrative Medicine for Episodic Migraine: an Update of Evidence from the Last 3 Years. Curr Pain Headache Rep. 2019; 23(2):10. DOI: 10.1007/s11916-019-0750-8

  17. Wen Y, Wang D, Fan G. Acupoint selection for acute migraine treated with acupuncture. Zhongguo Zhen Jiu. 2018; 38(11):1183-8. DOI: 10.13703/j.0255-2930.2018.11.013

  18. Andrasik F, Grazzi L, Sansone E, D’Amico D, Raggi A, Grignani E. Non-pharmacological Approaches for Headaches in Young Age: An Updated Re-view. Front Neurol. 2018; 9:1009. DOI: 10.3389/fneur.2018.01009

  19. Grazzi L, Sansone E, Raggi A, D’Amico D, De Giorgio A, Leonardi M, et al. Mindfulness and pharmacological prophylaxis after withdrawal from medication overuse in patients with Chronic Migraine: an effectiveness trial with a one-year follow-up. J Headache Pain. 2017; 18(1):15. DOI: 10.1186/s10194-017-0728-z

  20. Grazzi L, D’Amico D, Raggi A, Leonardi M, Ciusani E, Corsini E, et al. Mindfulness and pharmaco-logical prophylaxis have comparable effect on biomarkers of inflammation and clinical indexes in chronic migraine with medication overuse: results at 12 months after withdrawal. Neurol Sci. 2017; 38(Suppl 1):173-75. DOI: 10.1007/s10072-017-2874-0

  21. Oberg EB, Rempe M, Bradley R. Self-directed Mindfulness Training and Improvement in Blood Pressure, Migraine Frequency, and Quality of Life. Glob Adv Health Med. 2013;2(2):20-5. DOI: 10.7453/gahmj.2013.006Literatura citada

  22. Probyn K, Bowers H, Mistry D, Caldwell F, Under-wood M, Patel S, et al. Non-pharmacological self-management for people living with migraine or tension-type headache: a systematic review including analysis of intervention components. BMJ Open. 2017; 7(8):e016670. DOI: 10.1136/bmjopen-2017-016670

  23. Tavallaei V, Rezapour-Mirsaleh Y, Rezaiemaram P, Saadat SH. Mindfulness for female outpatients with chronic primary headaches: an inter-net-based bibliotherapy. Eur J Transl Myol. 2018; 28(2):7380. DOI: 10.4081/ejtm.2018.7380

  24. Wells RE, Burch R, Paulsen RH, Wayne PM, Houle TT, Loder E. Meditation for migraines: a pilot randomized controlled trial. Headache. 2014; 54(9):1484-95. DOI: 10.1111/head.12420

  25. Diener HC, Tassorelli C, Dodick DW, Silberstein SD, Lipton RB, Ashina M, et al. Guidelines of the Inter-national Headache Society for controlled trials of acute treatment of migraine attacks in adults: Fourth edition. Cephalalgia. 2019; 39(6):687-710. DOI: 10.1177/0333102419828967

  26. Rossi P, Di Lorenzo G, Malpezzi MG, Faroni J, Ce-sarino F, Di Lorenzo C, et al. Prevalence, pattern and predictors of use of complementary and alternative medicine (CAM) in migraine patients attending a headache clinic in Italy. Cephalal-gia. 2005; 25(7):493-506. DOI: 10.1111/j.1468-2982.2005.00898.x




2020     |     www.medigraphic.com